National DNA Day!
Aaron Michels, M.D., discovered that methyldopa—a therapy that has been used for 50 years to treat high blood pressure—may have…
FDA Breakthrough Therapy Designation for TTP399—A Potential First-in-Class Adjunct Therapy in T1D
The FDA granted Breakthrough Therapy designation for vTv Therapeutics’ TTP399 as an adjunct therapy to insulin for T1D.
(Beta Cell) Stressing You Out?
You thought that beta cells were passive participants in their own immune-mediated death, leading to type 1 diabetes (T1D)? Wrong.
Severe Low Blood Sugar: There’s a New Treatment Option
The FDA approved Zegalogue® (dasiglucagon) injection, for the treatment of severe hypoglycemia in children and adults with diabetes aged 6…
Keeping Your Kidneys Healthier, For Longer
Normally, the kidneys filter waste and extra water out of your blood to make urine. When your kidneys are damaged,…
I Still Have Diabetes, But with My CGM I’m Thriving
This educational content is made possible with support from Abbott, the makers of the FreeStyle Libre 2. Editorial control rests…
Bench to Bedside: Breakthrough T1D-nPOD Conference
The 13th nPOD Annual Meeting was held February 22-24, 2021, and featured some of the most world-renowned diabetes investigators.
Investigations by Leading Immune-Mediated Disease Research Organizations
Breakthrough T1D has partnered with the Lupus Research Alliance and the National Multiple Sclerosis Society to advance the understanding of…
Breakthrough T1D Launches Third Center of Excellence in New England
The Breakthrough T1D New England Center of Excellence will focus on protecting the stem cell-derived beta cells from rejection by…
Can a Psoriasis Drug Halt or Reverse Type 1 Diabetes?
Type 1 diabetes is one of the only major autoimmune diseases that doesn't have a disease-modifying therapy. A Breakthrough T1D clinical…
